Peter H. Jones, MD, discussed identifying high-risk patients and targeting specific lipid therapy to reduce risk of future cardiovascular disease events.
Daniel Einhorn, MD, from Scripps Whittier Diabetes Institute talks about the "debate of 2018": ACP's new guidance on controlling HbA1c levels in adults with diabetes.
Linda Grinnell-Merrick, MS, NP-BC, immediate past president of the Rheumatology Nurses Society, discusses the importance of a comprehensive evaluation of a patient with PsA, nonpharmacologic and...
In this podcast, David Hill, MD, answers our questions about managing chronic obstructive pulmonary disease (COPD) during the COVID-19 pandemic, including whether patients with COPD are at an increased risk...
